Alport syndrome and thin glomerular basement membrane disease

Journal of the American Society of Nephrology

Volumn 9, Issue 9, 1998, Pages 1736-1750

  Kashtan, Clifford E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4;

ALPORT SYNDROME; AUTOSOMAL RECESSIVE DISORDER; CLINICAL FEATURE; DISEASE ASSOCIATION; GENE LOCUS; GENE MUTATION; GLOMERULUS BASEMENT MEMBRANE; HEMATURIA; HUMAN; HYPERTENSION; IMMUNOFLUORESCENCE; KIDNEY FAILURE; LEIOMYOMATOSIS; MOLECULAR CLONING; NONHUMAN; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PROTEINURIA; REVIEW; TISSUE DISTRIBUTION; X CHROMOSOME LINKED DISORDER;

EID: 0031720662     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Guthrie LG: "Idiopathic," or congenital, hereditary and familial hematuria. Lancet 1: 1243-1246, 1902
2. Hurst AF: Hereditary familial congenital haemorrhagic nephritis occurring in sixteen individuals in three generations. Guy's Hosp Rep 3: 368-370, 1923
3. Alport AC: Hereditary familial congenital haemorrhagic nephritis. Br Med J 1: 504-506, 1927
4. Hinglais N, Grunfeld J-P, Bois LE: Characteristic ultrastructural lesion of the glomerular basement membrane in progressive hereditary nephritis (Alport's syndrome). Lab Invest 27: 473-487, 1972
5. Spear GS, Slusser RJ: Alport's syndrome: Emphasizing electron microscopic studies of the glomerulus. Am J Pathol 69: 213-222, 1972
6. Churg J, Sherman RL: Pathologic characteristics of hereditary nephritis. Arch Pathol 95: 374-379, 1973
7. McCoy RC, Johnson HK, Stone WJ, Wilson CB: Absence of nephritogenic GBM antigen(s) in some patients with hereditary nephritis. Kidney Int 21: 642-652, 1982
8. Kashtan C, Fish AJ, Kleppel M, Yoshioka K, Michael AF: Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis. J Clin Invest 78: 1035-1044, 1986
9. Atkin CL, Hasstedt SJ, Menlove L, Cannon L, Kirschner N, Schwartz C, Nguyen K, Skolnick M: Mapping of Alport syndrome to the long arm of the X chromosome. Am J Hum Genet 42: 249-255, 1988
10. Hostikka SL, Eddy RL, Byers MG, Hoyhtya M, Shows TB, Tryggvason K: Identification of a distinct type IV collagen α chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome. Proc Natl Acad Sci USA 87: 1606-1610, 1990
11. Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, Gregory MC, Skolnick MH, Atkin CL: Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248: 1224-1227, 1990
12. Zhou J, Reeders ST: The α chains of type IV collagen. Contrib Nephrol 117: 80-105, 1996
13. Kleppel MM, Fan WW, Cheong HI, Michael AF: Evidence for separate networks of classical and novel basement membrane collagen: Characterization of α3(IV)-Alport antigen heterodimers. J Biol Chem 267: 4137-4142, 1992
14. Gunwar S, Ballester F, Noelken M, Sado Y, Ninomiya Y, Hudson B: Glomerular basement membrane: Identification of a novel disulfide-cross-linked network of α3, α4, and α5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome. J Biol Chem 273: 8767-8775, 1998
15. Jefferson JA, Lemmink HH, Hughes AE, Hill CM, Smeets HJ, Doherty CC, Maxwell AP: Autosomal dominant Alport syndrome linked to the type IV collagen alpha 3 and alpha 4 genes (COL4A3 and COL4A4). Nephrol Dial Transplant 12: 1595-1599, 1997
16. Lemmink HH, Schröder CH, Monnens LAH, Smeets HJM: The clinical spectrum of type IV collagen mutations. Hum Mutat 9: 477-499, 1997
17. Renieri A, Bruttini M, Galli L, Zanelli P, Neri T, Rossetti S, Turco A, Heiskari N, Zhou J, Gusmano R, Massella L, Banfi G, Scolari F, Sessa A, Rizzoni G, Tryggvason K, Pignatti PF, Savi M. Ballabio A, De Marchi M: X-linked Alport syndrome: An SSCP-based mutation survey over all 51 exons of the COL4A5 gene. Am J Hum Genet 58: 1192-1204, 1996
18. Knebelmann B, Breillat C, Forestier L, Arrondel C, Jacassier D, Giatras J, Druout L, Deschennes G, Grunfeld JP, Broyer M, Gubler MC, Antignac C: Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am J Hum Genet 59: 1221-1232, 1996
19. Kawai S, Nomura S, Harano T, Harano K, Fukushima T, Osawa G: The COL4A5 gene in Japanese Alport syndrome patients: Spectrum of mutations of all exons. Kidney Int 49: 814-822, 1996
20. Antignac C, Zhou J, Sanak M, Cochat P, Roussel B, Deschenes G, Gros F, Knebelmann B, Hors-Cayla M-C, Tryggvason K, Gubler M-C: Alport syndrome and diffuse leiomyomatosis: Deletions in the 5′ end of the COL4A5 gene. Kidney Int 42: 1178-1183, 1992
21. Zhou J, Mochizuki T, Smeets H, Antignac C, Laurila P, de Paepe A, Tryggvason K, Reeders ST: Deletion of the paired α5(IV) and α6(IV) collagen genes in inherited smooth muscle tumors. Science 261: 1167-1169, 1993
22. Feingold J, Bois E, Chompret A, Broyer M, Gubler MC, Grunfeld JP: Genetic heterogeneity of Alport syndrome. Kidney Int 27: 672-677, 1985
23. Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler MC, Pirson Y, Verellen-Dumoulin C, Chan B, Schroeder CH, Smeets HJM, Reeders ST: Identification of mutations in the α3(IV) and α4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8: 77-82, 1994
24. Cheong HI, Kashtan CE, Kim Y, Kleppel MM, Michael AF: Immunohistologic studies of type IV collagen in anterior lens capsules of patients with Alport syndrome. Lab Invest 70: 553-557, 1994
25. Gubler MC, Knebelmann B, Beziau A, Broyer M, Pirson Y, Haddoum F, Kleppel MM, Antignac C: Autosomal recessive Alport syndrome: Immunohistochemical study of type IV collagen chain distribution. Kidney Int 47: 1142-1 147, 1995
26. Prockop DJ: Mutations in collagen genes as a cause of connective-tissue diseases. N Engl J Med 326: 540-546, 1992
27. Thorner PS, Zheng K, Kalluri R, Jacobs R, Hudson BG: Coordinate gene expression of the α3, α4 and α5 chains of collagen type IV: Evidence from a canine model of X-linked nephritis with a COL4A5 gene mutation. J Biol Chem 271: 13821-13828, 1996
28. Nakanishi K, Yoshikawa N, Iijima K, Nakamura H: Expression of type IV collagen α3 and α4 chain mRNA in X-linked Alport syndrome. J Am Soc Nephrol 7: 938-945, 1996
29. Sasaki S, Zhou B, Fan WW, Kim Y, Barker DF, Dension JC, Atkin CL, Gregory MC, Zhou J, Segal Y, Sado Y, Ninomiya Y, Michael AF, Kashtan CE: Expression of mRNA for type IV collagen α1, α5 and α6 chains by cultured dermal fibroblasts from patients with X-linked Alport syndrome. Matrix Biol 1998, in press
30. Cosgrove D, Meehan DT, Grunkemeyer JA, Kornak JM, Sayers R, Hunter WJ, Samuelson GC: Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome. Genes Dev 10: 2981-2992, 1996
31. Miner JJ, Sanes JR: Molecular and functional defects in kidneys of mice lacking collagen α3(IV): Implications for Alport syndrome. J Cell Biol 135: 1403-1413, 1996
32. Grunfeld J-P, Noel LH, Hafez S, Droz D: Renal prognosis in women with hereditary nephritis. Clin Nephrol 23: 267-271, 1985
33. Jansen B, Thorner P, Baumal R, Valli V, Maxie MG, Singh A: Samoyed hereditary glomerulopathy (SHG): Evolution of splitting of glomerular capillary basement membranes. Am J Pathol 125: 536-545, 1986
34. Rumpelt H-J: Hereditary nephropathy (Alport syndrome): Correlation of clinical data with glomerular basement membrane alterations. Clin Nephrol 13: 203-207, 1980
35. Meleg-Smith S, Magliato S, Cheles M, Carola RE, Kashtan CE: X-linked Alport syndrome in females. Hum Pathol 29: 404-408, 1998
36. Kim KH, Kim Y, Gubler MC, Steffes MW, Lane PH, Kashtan CE, Crosson JT, Mauer SM: Structure-functional relationships in Alport syndrome. J Am Soc Nephrol 5: 1659-1668, 1995
37. Kashtan CE, Gubler MC, Sisson-Ross S, Mauer M: Chronology of renal scarring in males with Alport syndrome. Pediatr Nephrol 12: 269-274, 1998
38. Wester DC, Atkin CL, Gregory MC: Alport syndrome: Clinical update. J Am Acad Audiol 6: 73-79, 1995
39. Barker DF, Pruchno CJ, Xiang X, Atkin CL, Stone EM, Deison JC, Fain PR, Gregory MC: A mutation causing Alport syndrome with tardive hearing loss is common in the western United States. Am J Hum Genet 58: 1157-1165, 1996
40. Johnsson L-G. Arenberg IK: Cochlear abnormalities in Alport's syndrome. Arch Otolaryngol 107: 340-349, 1981
41. Westergaard O, Kluyskens P, John HD: Alport's syndrome: Histopathology of human temporal bones. Oto Rhino Laryngol (Basel) 34: 263-272, 1972
42. Colville D, Savige J, Morfis M, Ellis J, Kerr P, Agar J, Fasset R: Ocular manifestations of autosomal recessive Alport syndrome. Ophthalmic Genet 18: 119-128, 1997
43. Nielsen CE: Lenticonus anterior and Alport's syndrome. Arch Ophthalmol 56: 518-530, 1978
44. Brownell RD, Wolter JR: Anterior lenticonus in familial hemorrhagic nephritis: Demonstration of lens pathology. Arch Ophthalmol 71:481-483, 1964
45. Streeten BW, Robinson MR, Wallace R, Jones DB: Lens capsule abnormalities in Alport's syndrome. Arch Ophthalmol 105: 1693-1697, 1987
46. Perrin D, Jungers P, Grunfeld JP, Delons S, Noel LH, Zenatti C: Perimacular changes in Alport's syndrome. Clin Nephrol 13: 163-167, 1980
47. Teekhasaenee C, Nimmanit S, Wutthiphan S, Vareesangthip K, Laohapand T, Malasitr P, Ritch R: Posterior polymorphous dystrophy and Alport syndrome. Ophthalmology 98: 1207-1215, 1991
48. Rhys C, Snyers B, Pirson Y: Recurrent corneal erosion associated with Alport's syndrome. Kidney Int 52: 208-211, 1997
49. Antignac C, Heidet L: Mutations in Alport syndrome associated with diffuse esophageal leiomyomatosis. Contrib Nephrol 117: 172-182, 1996
50. Epstein CJ, Sahud MA, Piel CF, Goodman JR, Bernfield MR, Kushner JH, Ablin AR: Hereditary macrothrombocytopenia, nephritis and deafness. Am J Med 52: 299-310, 1972
51. Naito I, Nomura S, Inoue S, Kagawa M, Kawai S, Gunshin Y, Joh K, Tsukidate C, Sado Y, Osawa G: Normal distribution of collagen IV in renal basement membranes in Epstein's syndrome. J Clin Pathol 50: 919-922, 1997
52. Nakanishi K, Yoshikawa N, Iijima K, Kitagawa K, Nakamura H, Ito H, Yoshioka K, Kagawa M, Sado Y: Immunohistochemical study of α1-5 chains of type IV collagen in hereditary nephritis. Kidney Int 46: 1413-1421, 1994
53. Kagawa M, Kishiro Y, Naito I, Nemoto T, Nakanishi H, Ninomiya Y, Sado Y: Epitope-defined monoclonal antibodies against type-IV collagen for diagnosis of Alport's syndrome. Nephrol Dial Transplant 12: 1238-1241, 1997
54. Kashtan CE, Kleppel MM, Gubler MC: Immunohistologic findings in Alport syndrome. Contrib Nephrol 117: 142-153, 1996
55. Yoshioka K, Hino S, Takemura T, Maki S, Wieslander J, Takekoshi Y, Makino H, Kagawa M, Sado Y, Kashtan CE: Type IV Collagen α5 chain: Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol 144: 986-996, 1994
56. Kalluri R, Shield CF, Todd P, Hudson BG, Neilson EG: Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J Clin Invest 99: 2470-2478, 1997
57. Kashtan CE, Kim Y: Distribution of the α1 and α2 chains of collagen IV and of collagens V and VI in Alport syndrome. Kidney Int 42: 115-126, 1992
58. Muda AO, Rahimi S, Renieri A, Rizzoni G, Massella L, Faraggiana T: Ultrastructural immunocytochemistry of collagenous and non-collagenous proteins in fast-frozen, freeze-substituted, and low-temperature-embedded renal tissue in Alport syndrome. J Pathol 182: 465-474, 1997
59. Zheng K, Thorner PS, Marrano P, Baumal R, McInnes RR: Canine X chromosome-linked hereditary nephritis: A genetic model for human X-linked hereditary nephritis resulting from a single base mutation in the gene encoding the α5 chain of collagen type IV. Proc Natl Acad Sci USA 91: 3989-3993, 1994
60. Tryggvason K, Heikkila P, Pettersson E, Tibell A, Throner P: Can Alport syndrome be treated by gene therapy? Kidney Int 52: 1493-1499, 1997
61. Grodecki KM, Gains MJ, Baumal R, Osmond DH, Cotter BVVE, Jacobs RM: Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme inhibitor. J Comp Pathol 117: 209-225, 1997
62. Kashtan CE, McEnery PT, Tejani A, Stablein DM: Renal allograft survival according to primary diagnosis: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 9: 679-684, 1995
63. Kalluri R, Weber M, Netzer K-O, Sun MJ, Neilson EG, Hudson BG: COL4A5 gene deletion and production of post-transplant anti-α3(IV) collagen alloantibodies in Alport syndrome. Kidney Int 45: 721-726, 1994
64. Brainwood D, Kashtan C, Gubler MC, Turner AN: Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. Kidney Int 53: 762-766, 1998
65. Ding J, Stitzel J, Berry P, Hawkins E, Kashtan C: Autosomal recessive Alport syndrome: Mutation in the COL4A3 gene in a woman with Alport syndrome and posttransplant antiglomerular basement membrane nephritis. J Am Soc Nephrol 5: 1714-1717, 1995
66. Lemmink HH, Mochizuki T, van den Heuvel LPWJ, Schroder CH, Barrientos A, Monnens LAH, van Oost BA, Brunner HG, Reeders ST, Smeets HJM: Mutations in the type IV collagen α3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet 3: 1269-1273, 1994
67. Ding J, Zhou J, Tryggvason K, Kashtan CE: COL4A5 deletions in three patients with Alport syndrome and posttransplant antiglomerular basement membrane nephritis. J Am Soc Nephrol 5: 161-168, 1994
68. Antignac C, Knebelmann B, Druout L, Gros F, Deschenes G, Hors-Cayla M-C, Zhou J, Tryggvason K, Grunfeld J-P, Broyer M, Gubler M-C: Deletions in the COL4A5 collagen gene in X-linked Alport syndrome: Characterization of the pathological transcripts in non-renal cells and correlation with disease expression. J Clin Invest 93: 1195-1207, 1994
69. Sessa A, Pietrucci A, Carozzi S, Tarelli LT, Tazzari S, Giordano F, Meroni M, Barrini G, Valente U, Renieri A, De Marchi M: Renal transplantation from living donor parents in two brothers with Alport syndrome. Nephron 70: 106-109, 1995
70. Lemmink HH, Nillesen WN, Mochizuki T, Schröder CH, Brunner HG, van Oost BA, Monnens LAH, Smeets HJM: Benign familial hematuria due to mutation of the type IV collagen α4 gene. J Clin Invest 98: 1114-1118, 1996
71. Saito A, Yamazaki H, Nakagawa Y, Arakawa M: Molecular genetics of renal diseases. Intern Med 36: 81-86, 1997
72. Tiebosch ATMG, Frederik PM, van Breda Vriesman PJ, Mooy JMV, van Rie H, van de Wiel TWM, Wolters J, Zeppenfeldt E: Thin-basement-membrane nephropathy in adults with persistent hematuria. N Engl J Med 320: 14-18, 1989
73. Dische FE, Weston MJ, Parsons V: Abnormally thin glomerular basement membranes associated with hematuria, proteinuria or renal failure in adults. Am J Nephrol 5: 103-109, 1985
74. Cosio FG, Falkenhain ME, Sedmak DD: Association of thin glomerular basement membrane with other glomerulopathies. Kidney Int 46: 471-474, 1994
75. Vogler C, McAdams AJ, Homan SM: Glomerular basement membrane and lamina densa in infants and children: An ultrastructural evaluation. Pediatr Pathol 7: 527-534, 1987
76. Steffes MW, Barbosa J, Basgen JM, Sutherland DER, Najarian JS, Mauer SM: Quantitative glomerular morphology of the normal human kidney. Kidney Int 49: 82-86, 1983
77. Dische FE: Measurement of glomerular basement membrane thickness and its application to the diagnosis of thin-membrane nephropathy. Arch Pathol Lab Med 116: 43-49, 1992
78. Nieuwhof CM, de Heer F, de Leeuw P, van Breda Vriesman PJ: Thin GBM nephropathy: Premature glomerular obsolescence is associated with hypertension and late onset renal failure. Kidney Int 51: 1596-1601, 1997